Literature DB >> 21953625

Folate, vitamin B(6) , vitamin B(12) , methionine and alcohol intake in relation to ovarian cancer risk.

Holly R Harris1, Daniel W Cramer, Allison F Vitonis, Mary DePari, Kathryn L Terry.   

Abstract

Folate, methionine, vitamin B(6) and vitamin B(12) may influence carcinogenesis due to their roles in the one-carbon metabolism pathway, which is critical for DNA synthesis, methylation and repair. Low intake of these nutrients has been associated with an increased risk of breast, colon and endometrial cancers. Previous studies that have examined the relation between these nutrients and ovarian cancer risk have been inconsistent and have had limited power to examine the relation by histologic subtype. We investigated the association between folate, methionine, vitamin B(6) , vitamin B(12) and alcohol among 1910 women with ovarian cancer and 1989 controls from a case-control study conducted in eastern Massachusetts and New Hampshire from 1992 to 2008. Diet was assessed via food frequency questionnaire. Participants were asked to recall diet one-year before diagnosis or interview. Logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (95% CIs). We also examined whether the associations varied by ovarian cancer histologies using polytomous logistic regression. We observed an inverse association between dietary vitamin B(6) (covariate-adjusted OR = 0.76, 95% CI 0.64-0.92; p(trend) = 0.002) and methionine intake (covariate-adjusted OR = 0.72, 95% CI = 0.60-0.87; p(trend) < 0.001) and ovarian cancer risk comparing the highest to lowest quartile. The association with dietary vitamin B(6) was strongest for serous borderline (covariate-adjusted OR = 0.49, 95% CI = 0.32-0.77; p(trend) = 0.001) and serous invasive (covariate-adjusted OR = 0.74, 95% CI = 0.58-0.94; p(trend) = 0.012) subtypes. Overall, we observed no significant association between folate and ovarian cancer risk. One-carbon metabolism related nutrients, especially vitamin B(6) and methionine, may lower ovarian cancer risk.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953625      PMCID: PMC3288483          DOI: 10.1002/ijc.26455

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  48 in total

1.  Overexpression of folate binding protein in ovarian cancers.

Authors:  G Toffoli; C Cernigoi; A Russo; A Gallo; M Bagnoli; M Boiocchi
Journal:  Int J Cancer       Date:  1997-04-22       Impact factor: 7.396

2.  Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women.

Authors:  T A Sellers; L H Kushi; J R Cerhan; R A Vierkant; S M Gapstur; C M Vachon; J E Olson; T M Therneau; A R Folsom
Journal:  Epidemiology       Date:  2001-07       Impact factor: 4.822

3.  Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues.

Authors:  Jane Key; Susan Hodgson; Rumana Z Omar; Tina K Jensen; Simon G Thompson; Alan R Boobis; Donald S Davies; Paul Elliott
Journal:  Cancer Causes Control       Date:  2006-08       Impact factor: 2.506

4.  Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women.

Authors:  Wang-Hong Xu; Martha J Shrubsole; Yong-Bing Xiang; Qiuyin Cai; Gen-ming Zhao; Zhi-xian Ruan; Jia-rong Cheng; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

Review 5.  Will mandatory folic acid fortification prevent or promote cancer?

Authors:  Young-In Kim
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

6.  Folate intake and risk of breast cancer characterized by hormone receptor status.

Authors:  Shumin M Zhang; Susan E Hankinson; David J Hunter; Edward L Giovannucci; Graham A Colditz; Walter C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-08       Impact factor: 4.254

7.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

8.  Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women.

Authors:  Martin Lajous; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Walter Willett; Isabelle Romieu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

9.  Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo.

Authors:  F Bottero; A Tomassetti; S Canevari; S Miotti; S Ménard; M I Colnaghi
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

10.  Evidence of high *OH radical quenching efficiency by vitamin B6.

Authors:  Jon M Matxain; Daniel Padro; Mikael Ristilä; Ake Strid; Leif A Eriksson
Journal:  J Phys Chem B       Date:  2009-07-23       Impact factor: 2.991

View more
  21 in total

Review 1.  Dynamics of DNA methylation in aging and Alzheimer's disease.

Authors:  Hasan A Irier; Peng Jin
Journal:  DNA Cell Biol       Date:  2012-02-07       Impact factor: 3.311

2.  Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.

Authors:  Megan S Rice; Megan A Murphy; Allison F Vitonis; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Int J Cancer       Date:  2013-07-09       Impact factor: 7.396

3.  Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis.

Authors:  Chenglin Li; Peizhan Chen; Pingting Hu; Mian Li; Xiaoguang Li; He Guo; Jingquan Li; Ruiai Chu; Wei Zhang; Hui Wang
Journal:  Mol Biol Rep       Date:  2013-10-17       Impact factor: 2.316

4.  Genetic variation in telomere maintenance genes in relation to ovarian cancer survival.

Authors:  Holly R Harris; Immaculata De Vivo; Linda J Titus; Allison F Vitonis; Jason Y Y Wong; Daniel W Cramer; Kathryn L Terry
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

5.  Menstrual pain and epithelial ovarian cancer risk.

Authors:  Ana Babic; Daniel W Cramer; Linda J Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Causes Control       Date:  2014-09-05       Impact factor: 2.506

6.  Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies.

Authors:  Anita Koushik; Molin Wang; Kristin E Anderson; Piet van den Brandt; Tess V Clendenen; A Heather Eliassen; Jo L Freudenheim; Jeanine M Genkinger; Niclas Håkansson; James R Marshall; Marjorie L McCullough; Anthony B Miller; Kim Robien; Thomas E Rohan; Catherine Schairer; Leo J Schouten; Shelley S Tworoger; Ying Wang; Alicja Wolk; Anne Zeleniuch-Jacquotte; Stephanie A Smith-Warner
Journal:  Cancer Causes Control       Date:  2015-07-14       Impact factor: 2.506

7.  The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.

Authors:  Amy L Shafrir; Megan S Rice; Mamta Gupta; Kathryn L Terry; Bernard A Rosner; Rulla M Tamimi; Jonathan L Hecht; Shelley S Tworoger
Journal:  Gynecol Oncol       Date:  2016-10-05       Impact factor: 5.482

8.  Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Authors:  M A Merritt; M De Pari; A F Vitonis; L J Titus; D W Cramer; K L Terry
Journal:  Hum Reprod       Date:  2013-01-12       Impact factor: 6.918

9.  Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes.

Authors:  Melissa A Merritt; Daniel W Cramer; Allison F Vitonis; Linda J Titus; Kathryn L Terry
Journal:  Int J Cancer       Date:  2012-07-24       Impact factor: 7.396

10.  Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.

Authors:  Lorenzo Galluzzi; Sabrina Marsili; Ilio Vitale; Laura Senovilla; Judith Michels; Pauline Garcia; Erika Vacchelli; Etienne Chatelut; Maria Castedo; Guido Kroemer
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.